| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.297 | 6.491 | 7.897 | 10.857 | 15.694 | 24.346 | 39.593 | 40.924 | 26.745 | 24.086 |
| Total Income - EUR | 6.297 | 6.491 | 7.897 | 10.857 | 16.139 | 25.219 | 41.047 | 42.072 | 27.900 | 24.086 |
| Total Expenses - EUR | 9.467 | 6.794 | 1.875 | 5.892 | 6.820 | 7.418 | 5.726 | 5.745 | 13.204 | 13.707 |
| Gross Profit/Loss - EUR | -3.169 | -303 | 6.021 | 4.966 | 9.319 | 17.801 | 35.322 | 36.327 | 14.696 | 10.380 |
| Net Profit/Loss - EUR | -3.358 | -498 | 2.061 | 4.640 | 8.844 | 17.067 | 34.095 | 35.305 | 14.422 | 9.672 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Neurosurgcons Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 31.838 | 30.543 | 29.068 | 27.594 | 26.137 | 24.737 | 23.303 | 22.487 | 24.717 | 23.262 |
| Current Assets | 7.811 | 7.987 | 736 | 396 | 51 | 5 | 38 | 5.041 | 507 | 3.742 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 7.810 | 7.987 | 0 | 0 | 0 | 0 | 0 | 11 | 11 | 57 |
| Cash | 2 | 1 | 736 | 396 | 51 | 5 | 38 | 5.030 | 496 | 3.684 |
| Shareholders Funds | -133.775 | -132.909 | -128.599 | -121.599 | -110.388 | -91.229 | -55.110 | -19.976 | -5.494 | 4.209 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 173.425 | 171.440 | 158.403 | 149.588 | 136.576 | 115.971 | 78.451 | 47.505 | 30.717 | 22.795 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurosurgcons Srl